CatchMe Therapeutics

CatchMe Therapeutics is dedicated to pioneering a new era of precision medicines by targeting the epitranscriptome machinery. With significant advancements in the field of RNA posttranscriptional modifications, CatchMe Therapeutics is at the forefront of developing innovative therapeutic solutions. The company focuses on manipulating components of the epitranscriptome machinery, particularly N6-methyladenosine (m6A), to address critical needs in human pathologies.

Located at 2 Ilan Ramon St., Ness Ziona, 7403635, IL, CatchMe Therapeutics is committed to leveraging the importance of m6A RNA modification in various cancer types and viral infections. The company's research aims to regulate the initiation, propagation, survival, and replication mechanisms of cancers through targeted therapies, addressing a significant gap in current treatment options.

CatchMe Therapeutics is poised to make a substantial impact on the biotechnology landscape. We invite the management of CatchMe Therapeutics to create a customized and exclusive company showcase and product listing on our platform, further enhancing their visibility and commercial development.